Literature DB >> 18332325

Role of cytogenetics in management of uveal melanoma.

Jerry A Shields1, Carol L Shields, Miguel Materin, Takami Sato, Arupa Ganguly.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18332325     DOI： 10.1001/archopht.126.3.416

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  8 in total

1.  Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma.

Authors:  Mohamed H Abdel-Rahman; Benjamin N Christopher; Mohammed F Faramawi; Khaled Said-Ahmed; Carol Cole; Andrew McFaddin; Abhik Ray-Chaudhury; Nyla Heerema; Frederick H Davidorf
Journal:  Mod Pathol       Date:  2011-04-15       Impact factor: 7.842

2.  Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens.

Authors:  Benjamin N Christopher; Colleen M Cebulla; Paul E Wakely; Frederick H Davidorf; Mohamed H Abdel-Rahman
Journal:  Exp Eye Res       Date:  2011-09-17       Impact factor: 3.467

Review 3.  Molecular prognostic testing and individualized patient care in uveal melanoma.

Authors:  J William Harbour
Journal:  Am J Ophthalmol       Date:  2009-10-02       Impact factor: 5.258

4.  Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.

Authors:  Mohamed H Abdel-Rahman; Colleen M Cebulla; Vishal Verma; Benjamin N Christopher; William E Carson; Thomas Olencki; Frederick H Davidorf
Journal:  Exp Eye Res       Date:  2012-05-05       Impact factor: 3.467

5.  Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.

Authors:  Mehdi Mazloumi; Pornpattana Vichitvejpaisal; Lauren A Dalvin; Antonio Yaghy; Kathryn G Ewens; Arupa Ganguly; Carol L Shields
Journal:  JAMA Ophthalmol       Date:  2020-03-01       Impact factor: 7.389

6.  Endoillumination (chandelier) and wide-angle viewing-assisted fine-needle aspiration biopsy of intraocular mass lesions.

Authors:  Pradeep Venkatesh; Seema Kashyap; Shreyas Temkar; Varun Gogia; Gaurav Garg; Rahul Kumar Bafna
Journal:  Indian J Ophthalmol       Date:  2018-06       Impact factor: 1.848

7.  Reactions to and desire for prognostic testing in choroidal melanoma patients.

Authors:  Tammy M Beran; Tara A McCannel; Annette L Stanton; Bradley R Straatsma; Barry L Burgess
Journal:  J Genet Couns       Date:  2009-05-07       Impact factor: 2.537

8.  p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

Authors:  Rubeta N Matin; Anissa Chikh; Stephanie Law Pak Chong; David Mesher; Manuela Graf; Paolo Sanza'; Valentina Senatore; Maria Scatolini; Francesca Moretti; Irene M Leigh; Charlotte M Proby; Antonio Costanzo; Giovanna Chiorino; Rino Cerio; Catherine A Harwood; Daniele Bergamaschi
Journal:  J Exp Med       Date:  2013-02-18       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.